SCHEMBL6818326

SCHEMBL6818326

COC(=O)COCCC(N)=O

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.44
LMNA P02545 4/20 0.38
KDM4E B2RXH2 1/20 0.38
HSD17B10 Q99714 2/20 0.36
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
ALDH1A1 P00352 3/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
CA12 O43570 1/20 0.33
CA14 Q9ULX7 1/20 0.33
RECQL P46063 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
SLC1A1 P43005 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8548559 0.84 TSHR (0.57) TSHRLMNAKDM4EHSD17B10MGAM
SCHEMBL6463788 0.81 TSHR (0.50) TSHRLMNAKDM4EHSD17B10MGAM
SCHEMBL22092864 0.80 TSHR (0.52) TSHRLMNAKDM4EHSD17B10MGAM
SCHEMBL5840370 0.79 TSHR (0.43) TSHRLMNAKDM4EHSD17B10MGAM
SCHEMBL7648165 0.79 TSHR (0.48) TSHRLMNAKDM4EHSD17B10MGAM
SCHEMBL3149738 0.77
SCHEMBL28630314 0.76 TSHR (0.40) TSHRLMNAKDM4EHSD17B10MGAM
SCHEMBL1335833 0.75 TSHR (0.56) TSHRLMNAKDM4EHSD17B10MGAM
SCHEMBL2449256 0.75 ALDH1A1 (0.37) TSHRLMNAKDM4EHSD17B10GAA
SCHEMBL260944 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE38551-E1 ADMINISTERING N-BENZYL-2- ACETAMIDO PROPIONAMIDE DERIVATIVES IN THE R CONFIGURATION, SUCH AS LACOSAMIDE RESEARCH CORPORATION TECHNOLOGIES, INC. 2004-07-06 US disclosed
EP-1038522-B1 Anticonvulsant enantiomeric amino acid derivatives RES CORP TECHNOLOGIES INC (US) 2004-06-02 EP disclosed
EP-0888289-B1 ANTICONVULSANT ENANTIOMERIC AMINO ACID DERIVATIVES RES CORP TECHNOLOGIES INC (US) 2001-06-13 EP disclosed
EP-1038522-A2 Anticonvulsant enantiomeric amino acid derivatives Research Corporation Technologies, Inc (US) 2000-09-27 EP disclosed
US-5773475-A DIPEPTIDES FOR CENTRAL NERVOUS SYSTEM DISORDERS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1998-06-30 US disclosed